The Lead Episode 19: A Discussion of Early versus Later Anticoagulation for Stroke with Atrial Fibrillation-The Lead Episode 19 Speaker Information

The Lead Episode 19 Speaker Information

Pdf Summary

In this discussion, the article "Early versus Later Anticoagulation for Stroke with Atrial Fibrillation" is being examined. The article was written by a large group of authors and published in the New England Journal of Medicine. The discussion is being hosted by Deepthy Varghese, who is joined by Niraj Sharma and Kamala P. Tamirisa as contributors.<br /><br />The article focuses on the timing of anticoagulation treatment for stroke prevention in patients with atrial fibrillation. The debate centers around whether early or later treatment is more effective in reducing the risk of stroke in these patients. The article presents data from the ELAN Investigators study, which compared outcomes in patients who received early anticoagulation within 48 hours of stroke onset versus those who received later anticoagulation.<br /><br />During the discussion, Niraj Sharma and Kamala P. Tamirisa provide their perspectives on the topic. Niraj Sharma discloses that he has no conflicts of interest, while Kamala P. Tamirisa discloses that she has received honoraria, speaking fees, and consulting fees from various medical organizations.<br /><br />Overall, this discussion presents an overview of the article "Early versus Later Anticoagulation for Stroke with Atrial Fibrillation" and provides insight from medical professionals on the topic.

Keywords

Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

New England Journal of Medicine

Deepthy Varghese

Niraj Sharma

Kamala P. Tamirisa

anticoagulation treatment

stroke prevention

atrial fibrillation

ELAN Investigators study

risk of stroke